NIH to Fund Genomics Studies Linking HLA and KIR Regions with Diseases | GenomeWeb

NEW YORK (GenomeWeb) – The National Institute of Health will award up to $3.4 million next year to fund genomics research programs and projects aimed at better understanding how two complex human genomic regions are involved in a range of immune system diseases.

The grants will support research programs focused on the HLA (human leukocyte antigen) and the KIR (natural killer cell immunoglobin-like receptor) genomic regions, which are involved in human susceptibility and resistance to immune-related diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.